ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2016.0.208 2016.0.208 2017-12-312017-12-31true2017-09-13falseNo description of principal activity 10960688 2017-09-12 10960688 2017-09-13 2017-12-31 10960688 2017-12-31 10960688 c:Director1 2017-09-13 2017-12-31 10960688 c:Director2 2017-09-13 2017-12-31 10960688 c:EntityHasNeverTraded 2017-09-13 2017-12-31 10960688 c:Micro-entities 2017-09-13 2017-12-31 10960688 c:AuditExempt-NoAccountantsReport 2017-09-13 2017-12-31 10960688 c:FullAccounts 2017-09-13 2017-12-31 10960688 c:PrivateLimitedCompanyLtd 2017-09-13 2017-12-31 iso4217:GBP

Registered number: 10960688









CELLPATH DIAGNOSTIC SERVICES LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 DECEMBER 2017

 
CELLPATH DIAGNOSTIC SERVICES LIMITED
REGISTERED NUMBER: 10960688

BALANCE SHEET
AS AT 31 DECEMBER 2017

2017
Note
£

  

Current assets
  
2

Net current assets
  
 
 
2

Total assets less current liabilities
  
2

  

Net assets
  
2


  

Capital and reserves
  
2


Notes

General information

CellPath Diagnostic Services Limited is a limited company incorporated in England and Wales Its registered office is 45 Pall Mall, London, SW1Y 5JG.

Average number of employees

The average monthly number of employees, including directors, during the period was 0.

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the period in question in accordance with section 476 of Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



................................................
PJH Webber
................................................
PLJ Webber
Director
Director


Date: 3 September 2018

Page 1